Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4236 results

Sort By:

Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Drinking

Study ID: NCT06670794
Start Date: 2026-01-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Web-based intervention for concerned partners

Psychoeducation control

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events

Study ID: NCT06379529
Start Date: 2026-01-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1050

Intervention / Treatment

NuvoAir clinical service

Sponsor

NuvoAir Medical PC

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Non-invasive Vagus Nerve Stimulation for Axial Spondyloarthritis Resistant to Biotherapies

Study ID: NCT04286373
Start Date: 2025-09
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

active stimulation then placebo stimulation

placebo stimulation then active stimulation

Sponsor

Public assistance - Paris hospitals

Source: clinicaltrials.gov

Share:
Add to list

Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

Study ID: NCT06648473
Start Date: 2026-01-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

MRI Scan

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

MRD-Guided Surveillance in Operable Colon Adenocarcinoma (I-III)(SURVEILLANCE-I)

Study ID: NCT06879873
Start Date: 2025-08-01
End Date: 2029-07-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

390

Intervention / Treatment
Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Study ID: NCT07064473
Start Date: 2025-07-28
End Date: 2029-12-21
Study Type

Interventional

Study Phase

Phase3

No. of Participants

11800

Intervention / Treatment

Vicadostat

Empagliflozin

Placebo matching Vicadrostat

Sponsor

Boehringer Ingelheim

Source: clinicaltrials.gov

Share:
Add to list

Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes

Study ID: NCT07046273
Start Date: 2025-08-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

496

Intervention / Treatment

P 027

Ozempic®

Sponsor

Shandong New Time Pharmaceutical Co., LTD

Source: clinicaltrials.gov

Share:
Add to list

HCMR Re-Imaging Study

Study ID: NCT07054073
Start Date: 2025-07-30
End Date: 2026-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

314

Intervention / Treatment

None - observational study

Sponsor

Christopher Kramer

Source: clinicaltrials.gov

Share:
Add to list

Endosymbionts in Trichomonas Vaginalis Pathogenicity

Study ID: NCT07082127
Start Date: 2025-10
End Date: 2027-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment
Sponsor

Medical University of Vienna

Source: clinicaltrials.gov

Share:
Add to list

Attachment and Prognostic Factor: the Implicit Approach

Study ID: NCT04954027
Start Date: 2026-09
End Date: 2028-09
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Questionnaires

Sponsor

Henri Laborit Hospital Center

Source: clinicaltrials.gov

Share:
Add to list